Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

By LabMedica International staff writers
Posted on 13 Oct 2026

Long Covid can involve persistent respiratory, cognitive, and gastrointestinal symptoms after acute infection, creating a difficult diagnostic and management challenge. More...

Because COVID-19 initially affects the respiratory tract, the airway microbiome may offer clues beyond previously observed gut microbiome changes. New findings now show distinct oral and lung microbiome patterns in people with the most severe long Covid symptoms.

The University of Dundee led the PHOSP-COVID research, which examined microbiome differences in people previously hospitalized with COVID-19. The study used DNA sequencing-based microbiome analysis of saliva and sputum samples to identify microbes present in the mouth and lungs. PHOSP-COVID is continuing to investigate the burden and management of long Covid.

The research included 771 people treated for COVID-19 between February 2020 and March 2021 at one of 38 UK hospitals. Participants were divided into four groups based on symptom severity five months after hospital discharge: very severe, severe, moderate, and mild. Six months after discharge, researchers collected saliva samples from the mouth and sputum samples from the lungs, then compared microbial variety and quantity with patient symptoms.

People with very severe long Covid showed clear differences in the microbiome of both the mouth and lungs compared with those without severe long Covid. The differences were linked to reduced lung function, neurocognitive symptoms including brain fog and problems with memory, attention, and concentration, and gastrointestinal symptoms including pain, nausea, diarrhea, and loss of appetite. An overabundance of lactic acid-producing bacteria was also associated with long Covid symptoms and with signs of inflammation in blood samples.

The findings were published in the European Respiratory Journal on October 11, 2026. The researchers noted that it remains unclear whether the microbiome changes existed before COVID-19 infection or developed afterward. They also stated that further work is needed to understand whether these microbiome changes improve over time and whether they could inform future treatment studies.

“What we don’t know is whether these changes came before a Covid infection, or whether the changes happened following a Covid infection. We also do not know what will happen to the microbiome in patients in subsequent years. We would love to know whether these changes get better with time,” said Professor James Chalmers, Chair of Respiratory Research at the University of Dundee.

Related Links
University of Dundee


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Image: Graphical Abstract (Nagy, G.R., Munkácsy, G., Murmu, A. et al. Beyond the linear genome: how reference bias threatens preventive medicine and geroscience. GeroScience, 2026. https://doi.org/10.1007/s11357-026-02436-z)

Study Shows How Genome Reference Bias Can Mislead Preventive Testing

Whole-genome sequencing is expected to play a growing role in preventive and predictive medicine, but accurate interpretation remains a major diagnostic challenge. The approach requires comparing billions... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.